Current status of antivascular therapy and targeted treatment in the clinic

Author： Dahl Olav   Borkamo Erling Dahl   Fluge Øystein  

Publisher： Informa Healthcare

ISSN： 1464-5157

Source： International Journal of Hyperthermia, Vol.24, Iss.1, 2008-02, pp. : 97-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science

By Tanaka Shinji   Arii Shigeki  

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 235-241

Springer Publishing Company

Access to resources Recommend Favorite

Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice

By Kudo Masatoshi  

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 242-255

Springer Publishing Company

Access to resources Recommend Favorite

Current status of molecular targeted therapy for hematologic malignancies: introduction

By Ueda Takanori  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 1-2

Springer Publishing Company

Access to resources Recommend Favorite

Current Status and Future Prospects of Gene Therapy: Focus on Allovectin-7® in the Treatment of Metastatic Melanoma

By Lewis Karl D.  

American Journal of Cancer, Vol. 4, Iss. 3, 2005-01 ,pp. : 137-144

Adis International

Access to resources Recommend Favorite

Neoadjuvant Therapy of Breast Cancer: Current Status

By Hennessy Bryan T.   Hanrahan Emer O.   Valero Vicente  

American Journal of Cancer, Vol. 5, Iss. 6, 2006-01 ,pp. : 411-425

Adis International

Access to resources Recommend Favorite